Adesis [ company website ]

Adesis Inc., a Delaware-based company, offers a range of chemistry services for early-stage to the leading life sciences companies. We provide support for early proof-of-concept projects, medicinal chemistry, lead optimization, custom syntheses and process development. We also specialize in the chemistry of orthogonally functionalized azaheterocycles (pyridines, azaindoles, piperidines and pyrrolidines). We aim to create value for our clients.

Almac Group [ company website ]

Almac Group provides world-class, integrated solutions to the global pharmaceutical and biotechnology industries. Our services include process R&D, custom synthesis of API; micronization, 14C radio-labeling, formulation and analytical development; commercial-scale manufacture; packaging; storage; QP release; supply chain management; diagnostic/genomic services, preparation of clinical supplies and technology solutions (IVRS /Web/EDC).

Alphora Research [ company website ]

Alphora Research Inc. provides API technology development services for the scale up of complex small molecules with pharmaceutical applications. Alphora's services include process development, analytical development and validation, stability testing and cGMP synthesis. Alphoras 26,000 sq.ft. facility includes cGMP Kilo Labs and Pilot Plant operations and supporting organic and analytical laboratories.

Please see our press release about our $2M Capital Expansion Program that may be viewed at http://www.alphoraresearch.com/new.

AMRI [ company website ]

AMRI is uniquely positioned in the marketplace to provide a competitive advantage to a diverse group of customers. Our reputation of providing the highest quality service and a variety of pricing options provides more companies with the security of sourcing discovery, development, small and large scale manufacturing projects throughout our global network of research and manufacturing facilities.

Apeloa Kangyu [ company website ]

Ash Stevens [ company website ]

Ash Stevens is an established pharmaceutical contractor that develops, registers, and manufactures Active Pharmaceutical Ingredients (APIs). Founded in 1962, Ash Stevens has a long and successful history of delivering APIs on time and on budget. Behind our success is an experienced team of talented scientists and regulatory experts committed to providing the highest quality of service. Ash Stevens offers a comprehensive and flexible package of manufacturing services to support early-stage development, FDA registration, and commercialization.

Asymchem

Asymchem is one of the world’s leading global companies for producing pharmaceutical chemicals/API’s, providing integrated services that range from drug discovery to commercialization. With a workforce or over 1000 well-trained professionals and some of the most modern facilities in the world, Asymchem has supported many companies, large and small, at all stages of the pharmaceutical research and development chain. Please visit www.asymchem.com for more information.

Bachem Americans Inc. [ company website ]

Bachem is an independent, technology-based, public biochemicals company providing full service to the pharma and biotech industry. Bachem is specialized in the process development and the manufacturing of peptides and complex organic molecules as active pharmaceutical ingredients (APIs), as well as innovative biochemicals for research purposes. With headquarters in Bubendorf, Switzerland, and affiliates in Europe and the US, Bachem works on a global scale and holds a leading position in the field of peptides.

Cambridge Major Laboratories [ company website ]

Cambridge Major Laboratories is a leading global chemistry outsourcing partner to the pharmaceutical and biotechnology industries, producing pharmaceutical intermediates and Active Pharmaceutical Ingredients. The Company has experienced explosive growth the past decade, and boasts a long, successful FDA inspection history. CML operates from three facilities in the US and Europe.

Carbogen Amcis [ company website ]

CARBOGEN AMCIS AG combines world-class chemistry skills to provide seamless drug substance development and commercialization services for leading pharmaceutical and biotechnology companies. Through our customised offering we provide an array of integrated services operated in a fully cGMP compliant infrastructure, including a dedicated High Potency Facility.  These services supports faster, safer drug development with improved cost efficiency, helping our clients make decisions more quickly and progress more candidates through the pipeline in a shorter period of time.

Chemical Transfer Partnership [ company website ]

Chiral Technologies, Inc. [ company website ]

DIVERCHIM [ company website ]

DIVERCHIM is a privately owned company engaged in innovative chemistry based drug (and materials) discovery and development. We offer a broad range of integrated organic chemistry R&D capabilities and our proprietary technologies to pharmaceutical, biotechnology, agrochemical, and cosmetic companies.

DIVERCHIM is committed to carrying out the customer's confidential contract research on a fee for service basis without downstream royalty payments. We assure complete confidentiality and technology transfer in the case of exclusive methodology development. Since January 2000, Diverchim has conducted R&D projects in collaboration with more than 20 pharmaceutical and biotechnology companies throughout the EC. Our Strengths include the highest scientific and quality standards, strong emphasis on customer service, excellent scientific staff and technology capabilities.

Evonik [ company website ]

Evonik, formerly known as Degussa, has been a leader in chemical catalysts for almost 40 years. Throughout this time, customers all over the world have been able to rely on us as a competent and trustworthy partner. Today, Evonik has two major disciplines in catalysis – homogeneous and heterogeneous catalysis – grouped under one roof. Not only does this make Evonik unique, but it also gives our customers the flexibility to find the most cost-efficient solution for their needs.

With its homogeneous and heterogeneous catalysts for batch, semi-batch and continuous processes, Evonik serves the following industries:

• life sciences and fine chemicals
• industrial chemicals and intermediates
• polymers.

It is our objective to work with you to develop and scale up tailor-made catalysts, which will make your production processes more reliable, more efficient and more predictable. Interdisciplinary, highly-qualified business teams at regional and international levels are integrated in the value-adding chain of our customers.

Evotec [ company website ]

Evotec is a leader in the discovery and development of novel small molecule drugs. The Company has built substantial drug discovery expertise and an industrialized platform that can drive new innovative small molecule compounds into the clinic. In addition, Evotec has built a deep internal knowledge base in the treatment of diseases related to neuroscience, pain, and inflammation. Leveraging these skills and expertise the Company intends to develop best-in-class differentiated therapeutics and deliver superior science-driven discovery alliances with pharmaceutical and biotechnology companies. Evotec has long-term discovery alliances with partners including Boehringer Ingelheim, CHDI, Novartis, Ono Pharmaceutical and Roche. The Company has a P2X 7 antagonist for the treatment of inflammatory diseases in clinical development and a series of preclinical compounds and development partnerships, including a strategic alliance with Roche for EVT 101, a subtype selective NMDA receptor antagonist for use in treatment-resistant depression.

Ferro Pfanstiehl Laboratories [ company website ]

Ferro Pfanstiehl Laboratories, Inc. is based in Waukegan, Illinois and manufactures commercial quantities of specialty and blocked sugars,high-purity low-endotoxin carbohydrates, pharmaceutical intermediates, and high-potency active pharmaceutical ingredients under current good manufacturing (cGMP) conditions and has more than 20 active US and international Drug Master Files.

Gelest, Inc.

Gelest Inc. is recognized world-wide as a leader and innovator in materials science and technology. Gelest manufactures and provides organosilicon and metal-organic compounds serving advanced technology markets though a customer driven approach. Please visit www.gelest.com for more information.

GVK BIO [ company website ]

GVK Biosciences is one of India's premier contract research organizations, providing an integrated platform of research services across the pharmaceutical research & development value chain to a growing number of global pharma and biotech companies. GVK BIO combines science, innovation and resources to help clients address their drug discovery and development challenges in the areas of Medicinal & Process Chemistry, Biology, Informatics, Clinical Pharmacology, Clinical Research and KPO. The company aims to become a preferred partner of choice for collaborative research projects.

Heraeus [ company website ]

Heraeus supplies an extensive number of precious metal specialty Chemicals including many organometallics and homogeneous catalysts that are usedin a multitude of key technologies all over the world. Our products enjoy unanimous level of acceptance whether they are used in the production, R&D or analytical sections of the chemical, pharmaceutical, petrochemical, automotive, plating and electronics industries.

Hovione [ company website ]

Hovione is a world-class company dedicated to the cGMP development and manufacture of APIs both as a CMO and API supplier. With FDA inspected plants in Europe, Asia and New Jersey, USA, HOVIONE is committed to superior customer service, quality and regulatory support. Our capabilities include process chemistry, analytical development, worldwide regulatory affairs, particle design and kilo to multi - ton manufacture of APIs under FDA and ICH cGMP standards. We offer APIs for all drug delivery systems, from oral to injectable and from inhalation to topical applications.With a 50 year track record in API development, our ability to provide customers with timely and reliable solutions that are dependable and economical has given us a worldwide reputation for quality products, superior customer service and regulatory compliance.

IRIX Pharmaceuticals [ company website ]

IRIX Pharmaceuticals is a recognized CRO/CMO specializing in Small Molecule APIs and Advanced Intermediates. IRIX has the expertise and experience to solve very complex chemistry challenges while meeting aggressive clinical delivery timelines. IRIX has High Containment, High Pressure, Cryogenic, Beta-Lactam and Controlled Substances capabilities. We have two US facilities both of which have been successfully inspected by the FDA along with additional laboratory facilities in St. Petersburg, Russia.

J-Star Research [ company website ]

J-STAR Research, J-STAR, based in South Plainfield, NJ is capable of tackling some of the most challenging chemistry problems in the industry including developing optimal synthetic routes, process research, scale up, synthesis of metabolites and impurities, developing novel synthetic strategies and cGMP manufacturing. The company was founded by a Dr. Andrew Thomson from Merck over ten years ago.

Johnson Matthey [ company website ]

Johnson Matthey Pharma Services (JMPS) provides development and manufacturing services for active pharmaceutical ingredients (APIs).  Located ~35 miles west of the Boston/Cambridge area, our recently built facility (2001) offers a design that incorporates both kilo-labs and pilot plant with expansion opportunity.  Services provided at JMPS are crucial for development and manufacturing needs of new chemical entities (NCEs) bound for clinical trials and market-approval (commercial use).  Strong cGMP and regulatory compliance underscores our services for custom synthesis, process development, scale-up, optimization, validation, and medicinal chemistry.  Beyond traditional chemistry services, we can provide solutions for complex molecules by leveraging technologies within our site and the Johnson Matthey group.  These technologies include separation technologies (SMB, chiral separations, prep HPLC, diafiltration, etc.), asymmetric/chiral development and analytical technologies, and catalysts (process).  Our services are retained for a variety of compounds including small molecules, natural products (extraction), controlled drug substances, and highly potent active ingredients (HPAI). We are able to offer a wide range of manufacturing scale from grams to hundreds of kilograms. To round out these services, our regulatory department has an impeccable track record with FDA compliance audits, and provides CMC, IND, and NDA support to our client’s regulatory filings.

Kanata Chemical Technologies [ company website ]

Kanata Chemical Technologies Inc. is a chemistry R&D organization dedicated to the development and application of innovative catalyst technologies and processes. Our activities include the design and synthesis of catalyts, pharmaceutical precursors and compounds, chiral intermediates, fine chemicals, flavors and fragrances. Our mission is the practical application of safe, environmentally friendly, cost-effective and sustainable solutions to chemical synthesis.

Lonza [ company website ]

LAXAI is a contract research organization established in 2004. Headquartered in New Jersey, USA with R&D facilities both in the US and India, Laxai leverages on the US / India presence by providing top quality & cost effective medicinal chemistry services. With one of the highest chemist to analytical instrument ratio in the industry, Laxai\'s highly talented Ph.D chemists and Project Managers have hands on problem solving experience and excellent communication skills. Project management support for all offshore projects is provided by Laxai Scientists based in the US.

Laxai offers Medicinal Chemistry, Process R&D, Analytical and Biology services. Our chemistry capabilities include:

• Key Building blocks , Scaffolds , Intermediates required to make several novel analogues to be screened in in-vitro studies
• Novel Analogues from a Lead molecule to optimize its pharmacological activity
• Focused libraries of 100- 200 compounds per scaffold to optimize the pK properties of a Lead molecule
• Reference Standards useful in in-vitro and in-vivo biological screens - >99% purity
• Custom synthesis of a Lead molecule in 100g scale to carry out pre clinical toxicological studies
• Route Scouting, Parameter Optimization, Scale up
• Method Development & Validation as per ICH guidelines
• Long Term and Accelerated Stability Studies
• Physicochemical Property Determination

Mercachem [ company website ]

• Synthesis of building blocks, scaffolds, screening- and reference compounds
• Synthesis of focused libraries

Process R&D Services:

• Production route development and scouting
• Small bulk supply (~1 kg, non-GMP)
• Catalyst screening and reaction optimization

Micron Technologies Inc [ company website ]

Micron Technologies provides contract particle size reduction and analytical services for the pharmaceutical and biotech industries. We offer micronization, mechanical milling, and classification in isolated processing suites. Our analytical laboratory offers material characterization testing, including but not limited to, particle size, TGA, DVS, XRPD, DSC, stability, method development and validation. US and UK facilities are FDA inspected.

Nation Ford Chemical [ company website ]

Founded in 1977, Nation Ford Chemical Co. is one of America’s most respected custom manufacturers of specialty organic chemicals. The company specializes in the production of a variety of organic intermediates, solvent dyes and pigments for a broad range of customers worldwide.

Neuland Laboratories

For almost twenty five years, Neuland has been at the forefront of aiding and accelerating the drug development and manufacturing process. Deriving its core strength from a deep understanding of complex chemistry and a proven expertise in manufacturing.  The company has established a position which enables it to deliver reliable solutions and services to the global pharmaceutical industry.

Neuland today is a manufacturer of Active Pharmaceutical Ingredients and provider of Contract Research Services. The company has two US FDA and EDQM compliant manufacturing sites and state-of-the-art R&D center close to Hyderabad, India.

Neuland's strength lies in its ability to partner with companies at an early stage, where speed and effectiveness are important and continue supporting them even after commercial launch.

Nissan Chemical Industries [ company website ]

Nissan Chemical Industries provides custom manufacturing and process development services for APIs and their intermediates from pre-clinical to commercial production stages. In addition, we offer analytical method development, stability testing, and filing of DMFs. Our company has various technologies for asymmetric synthesis, such as epoxidation, anti-selective hydrogenation, aldol reaction, and Michael reaction, for manufacturing optically active substances. We also have been working on AZADO, an ultra-highly active catalyst for alcohol oxidation, for commercial development.

Novasep [ company website ]

In order to meet increasing demand for exclusive synthesis, Novasep has invested in new facilities/capacities for ozonolysis and carbonylation, as well as for highly potent molecules handling and synthesis. This reinforces the broad range of services in synthesis and purification already offered by Novasep to the life science industries.

PCAS-Nanosyn [ company website ]

PCAS and Nanosyn are pleased to introduce their joint venture, PCAS-Nanosyn LLC. The JV is designed to bridge the capabilities of the two parent companies to offer our customers a seamless transition for custom chemical services from discovery chemistry at Nanosyn through to commercial scale API and fine chemical production at PCAS. The primary site of the JV is the cGMP kilolab asset and staff, formerly known as Seres Laboratories, and its 30 year experience base as a FDA registered site. With six, separate cGMP suites, including two, certified Class 10,000 clean rooms, the PCAS-Nanosyn site combines small company personal service and flexibility with large company derived expertise for process identification, development, scale-up, and manufacture under cGMP protocols. Please stop by our booth and share our excitement in this new venture, and visit our websites for more information at www.pcas-nanosyn.com; www.pcas.fr.com; and www.nanosyn.com.

PCI Synthesis

PCI Synthesis is a custom chemical manufacturer of new chemical entities (NCEs), generic APIs, and other specialty chemical products. PCI Synthesis offers a turnkey solution for all the steps needed to develop a final API, including process research, process development, analytical development, process validation, regulatory support, and FDA filing. PCI Synthesis operates two FDA inspected cGMP sites in the greater Boston area. The company has its headquarters and commercial manufacturing facilities located in Newburyport, MA while its small scale manufacturing and R&D facility is located in Devens, MA.

PharmaCore, Inc. [ company website ]

Since 2000, PharmaCore® has performed a variety of chemistry services for leading pharmaceutical and biotechnology companies including: custom organic synthesis; cGMP scale-up; development of novel molecular building blocks; chemical process research and development; and medicinal chemistry services.  Our success is due to our competitive pricing, our unwavering commitment to customer service and to the talent and experience of our scientists, most of whom hold doctorates in organic chemistry.

PharmaZell [ company website ]

PharmaZell offers to its clients standard and custom made APIs and intermediates as well as all chemical, pharmaceutical development services and regulatory activities required to bring a pharmaceutical product to the market. PharmaZell develops innovative processes for APIs and Intermediates through its R&D groups that cover all scales from laboratory to commercial production. Through the acquisition of GEA, PharmaZell provides fully vertically integrated development programmes from API to finished dosage form including regulatory documentation, procedures and strategies.

Piramal Healthcare [ company website ]

Pharma Solutions is the Contract Development and Manufacturing division of Piramal Healthcare (erstwhile known as Nicholas Piramal) Pharma Solutions is one of the very few Contract Manufacturing Organizations (CMOs) that can provide end-to-end support for bringing a drug to market or managing the life cycle of a launched drug. We offer Clinical Phase API synthesis and Formulations Development services and scale up to Commercial API and Finished Dosage form supply.

Ricerca Biosciences [ company website ]

Ricerca is the only North American CRO to offer the unique IP-IND^SM concept to pharmaceutical and biotechnology companies. The site encompasses all discovery and development services required to bring a target or drug candidate to a complete IND submission. The ability to perform both chemistry (medicinal chemistry, process chemistry, cGMP API kilo-lab and pilot plant production, complete analytical) and biology (DMPK, ADME, full toxicology, safety pharmacology, animal efficacy models, bioanalytical) as well as report writing and regulatory services at one site makes Ricerca the provider of choice for virtual, small, and medium-sized pharmaceutical companies seeking a successful IND submission.

Rohner, Inc.

We focus on the specific challenges of scale-up and large-scale TMC processes. Our equipment is designed to meet the special needs of those reactions. Our R&D efforts address all specific TMC issues, such as catalyst activity, handling and sourcing, as well as noble metal removal and catalyst recycling. We have extensive expertise in carbonylation, catalytic coupling reactions and asymmetric hydrogenation. Moreover, we collaborate with the leading technology providers in these fields. As the only independent provider of TMC worldwide, we always have a complete solution to your needs, including issues such as IP and reliable access to the respective catalyst.

SAFC

SAFC Pharma is a complete pipeline partner for the development, manufacturing and testing of both pharma and biopharma APIs, from preclinical to commercialization. By providing customers with access to the widest range of manufacturing capabilities, including traditional API and emerging technologies, SAFC helps customers accelerate their drug development programs. www.safcpharma.com.

Saltigo [ company website ]

Saltigo offers you a comprehensive set of services ranging from route selection, synthesis and process development, full analytical services, manufacturing at small scale under CGMP and ISO, regulatory expertise/support, and professional project management.

SBI Fine Chemicals [ company website ]

SBI Fine Chemicals Inc. works to enable research scientists and manufacturing chemists to achieve their project and business goals. We provide custom solutions that include new molecule development, lead-optimiztion, custom synthesis of advanced intermediates through process development, and scale-up for commercial manufacturing. SBI is backed by a team whose goal is to provide best practice expertise to clients working around the world. The SBI Team comprises of experienced Chemical Engineers and other technical personnel. Our motivated team has experience in a variety of chemistries, including Asymmetic Synthesis, Heterocycles, Amino Acids, Small Peptides, Resins and Linkers, etc.

Scynexis [ company website ]

SCYNEXIS is a premier drug discovery and development company delivering effective and innovative drug pipeline solutions to human and animal health pharmaceutical and global health partners. Our drug discovery and development services take your compounds from concept to clinic with speed and innovation. They are available on a fee for service basis or may be conducted in a shared risk arrangement.

Selcia Ltd. [ company website ]

For pharmaceutical companies worldwide we provide high quality radiolabelled compounds for metabolism, mass balance and microdosing studies including 14C-radiotracers for human volunteer studies prepared under strict adherence to GMP concepts. Our products are fully characterised by NMR, MS and radio-HPLC and come with an industry leading data package documenting synthesis and analysis including. GLP certification is available. We also offer rapid re-purification, storage and stock management of radiochemicals. Selcia combine knowledge and expertise in custom radiolabelling with regular client communication to ensure each project fulfils our customers unique requirements.. A leading provider of integrated drug discovery, medicinal chemistry and 14-C custom radiolabelling services Selcia is a privately held company with more than 60 employees operating from state-of-the-art laboratories near London, United Kingdom.

Senn Chemical [ company website ]

Established in 1963, Senn Chemicals is a premier business partner in the development, scale up, and manufacture of carbohydrates, fine chemicals and peptides: peptidomimetics, glycoeptides, lipopeptides for pharmaceutical, biotechnology, cosmetic and diagnostic clients. Senn offers products via catalog sales, and upon custom manufacturing under cGMP to meet specific customer requirements.

Siegfried USA [ company website ]

Siegfried is a globally active, independent Swiss company. As a supplier and service provider for the worldwide pharmaceutical industry, we concentrate on the development and production of pharmaceutical drug substances and customer-manufactured finished drugs, and offer all related services. We focus on maintaining the highest level of competence, working together with our clients as partners. Our specific know-how in process development, chemical and pharmaceutical production, and managing complex outsourcing projects is used to contribute significantly to the success of our customers.

Solid Form Solutions [ company website ]

Solid Form Solutions is a world leading contract research organization (CRO) providing the pharmaceutical industry with polymorph, salt and co-crystallisation screening services. Our services also include crystallisation development, particle development as well as basic physical properties / developability characterisation. Our aim is to be flexible, understand our client’s solid form problems and recommend workable solutions. Whether our expertise is required to deliver a solid form screening program or tackle specific problems encountered during drug manufacture, Solid Form Solutions will provide an unrivalled service.

Solvias [ company website ]

Solvias is a privately held company located in Basel/Switzerland. With over 300 highly qualified employees, Solvias supports the research and development of new drug substances and the optimization of manufacturing processes for pharmaceutical, biotechnology and life science companies worldwide. Customers benefit from a wide range of experience in the following areas: Chemical Development and cGMP Manufacturing , Catalysis, Analytical Services, Process analytical technologies and, Polymorphism, salts and crystallization. All analytical services are cGMP-approved by the FDA and Swiss authorities.

SwRI [ company website ]

SwRI provides services for custom synthesis, medicinal chemistry, API/intermediate synthesis and formulation development. SwRI also provides microencapsulation-based formulation and controlled release drug delivery technologies for multiple delivery platforms, using spray drying and other particle forming and polymorph controlling capabilities. SwRI has dedicated cGMP & cGLP facilities for drug product preparation.

SynQuest Labs [ company website ]

SynQuest Laboratories and Central Glass Germany are wholly owned subsidiaries of Central Glass Company (Japan). SynQuest is a technology based manufacturer specializing in fluorine compounds. Services include custom synthesis, contract manufacturing, bulk intermediates. It also markets a research catalog containing a wide range of gases, aliphatic and aromatic fluorine compounds, including building blocks, chiral chemicals, mass spectrometry markers, etc.

Ubichem, Inc. [ company website ]

Ubichem provides a comprehensive range of chemistry services (on lab to pilot plant scale) to support early pharmaceutical development including cGMP API and intermediate manufacture, process research and development, analytical method development and validation, and radiolabelling. Our expertise helps to minimise the risks associated with the scale-up of medicinal chemistry routes. Reliability and excellent problem-solving skills mean Ubichem is a preferred partner for many pharmaceutical and biotech companies.

Umicore [ company website ]

Umicore is a materials technology group focused on application areas where its expertise in materials science, chemistry and metallurgy can make a real difference.

Umicore Precious Metals Chemistry globally markets chemicals, catalysts and metal separation technologies having proven efficiency in many industrial scale catalytic and non-catalytic applications.

Our Business Development team supports the Life Science industry through dedicated technology platforms:

• Chiralyst – chiral ligands and catalysts
• Umicore CX – Pd N-heterocyclic carbene catalysts for cross-coupling reactions
• Umicore M – industrial Ru metathesis catalysts

Dedicated to its customers' success, Umicore creates value through the entire catalyst life-cycle management.

UQUIFA [ company website ]

UQUIFA has more than fifty years experience in successfully improving and commercialising complex chemical processes for the pharmaceutical industry.

Major Services:

• Development of novel synthetic routes and optimisation of existing laboratory processes.
• Scale-up from Laboratory to Pilot Plant.
• Scale-up from Pilot Plant to commercial.
• Optimising laboratory developed routes of synthesis to reduce isolation steps, improve yield, reduce batch production time and eliminate the use of toxic and/or dangerous reagents.
• Transfer of commercial scale processes

All UQUIFA sites operate under cGMP conditions and all sites have been inspected and approved by the FDA.

Wilmington PharmaTech [ company website ]

Wilmington PharmaTech is a full service CRO serving pharmaceutical and biotechnology companies in five major areas including 1) cGMP synthesis, 2) Salt and Polymorph Studies (to discover a suitable salt and crystal form), 3) FTE Research (process or medicinal chemistry performed either in the US or China), 4) Analytical Services (e.g. method development, method validation, trace analysis), and 5) Bulk Intermediate Synthesis (kgs to tons). Wilmington PharmaTech currently has two locations in Newark, Delaware (Delaware Technology Park and Pencader Corporate Center) with process research labs, solid state chemistry lab, analytical lab, and cGMP kilo labs. The company is also expanding its non-GMP bulk intermediate production in China.